The largest database of trusted experimental protocols

Gen5 chs 2

Manufactured by Agilent Technologies
Sourced in United States

Gen5 CHS 2.07 software is a data analysis and instrument control software designed for Agilent's cell-based assays. It provides functions for data acquisition, analysis, and reporting of cellular health and status using Agilent's cell analysis platforms.

Automatically generated - may contain errors

2 protocols using gen5 chs 2

1

NLRP6 and ERβ Knockdown Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded in 96-well culture plates at appropriate density were first primed with LPS (100 ng/mL) (00497693, Thermo Fisher Scientific) for 4 h, followed by treatment of 3% DSS for 24 h prior to treatment for 48 h with ERB-041 (1 mM) and TNF-a (5 ng/mL) (Z01001-10, Genscript) or IL-1b (10 ng/mL) (Z02922-10, Genscript). The cell activity was tested according to CCK-8 (40203ES76, YEASEN) protocol. The absorbance at 450 nm was obtained by a microplate reader with Gen5 CHS 2.07 software (BioTek, USA).
Generation of knockdown stable cells pLVX-shRNA2 (PT4052-5, Clontech), psPAX2 (PVT2320, Life Science Market) and pMD2.G (PVT2321, Life Science Market) vectors were purchased from Nova Lifetech Limited (Hongkong, China). Lentivirus-mediated shRNA targeting NLRP6 and ERb mRNA sequences (Listed in Table S1) were obtained from Genscript Biotech Corporation.
pLVX-shNLRP6/pLVX-shERb, psPAX2, and pMD2.G were transfected into the HEK239T cells. The supernatant containing lentivirus was harvested after 40 h and then added into the NCM-460 cells. After 24 h, the medium was replaced with fresh medium. 48 h later, cells were cultured in selection medium containing 10 mg/mL puromycin. All these stable transfected cells were tested regularly by western blotting analysis to ensure the efficiency of down-regulation.
+ Open protocol
+ Expand
2

DSS-Induced Inflammatory Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded in 96-well culture plates at appropriate density were first primed with LPS (100 ng/ml) (00497693, Thermo Fisher Scientific) for 4 h, followed by treatment of 3% DSS for 24 h prior to treatment for 48 h with ERB-041 (1 μM) and TNF-α (5 ng/mL) (Z01001-10, Genscript) or IL-1β (10 ng/mL) (Z02922-10, Genscript).
The cell activity was tested according to CCK-8 (40203ES76, YEASEN) protocol. The absorbance at 450 nm was obtained by a microplate reader with Gen5 CHS 2.07 software (BioTek, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!